Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought

Authors :: Palou, J.
Pisano, F.
Sylvester, R.
Joniau, S.
Serretta, V.
Larre, S.
Witjes, J.A.
Grotenhuis, A.J.
Karnes, R.J.
Gontero, P.
Palou, J.
Pisano, F.
Sylvester, R.
Joniau, S.
Serretta, V.
Larre, S.
Witjes, J.A.
Grotenhuis, A.J.
Karnes, R.J.
Gontero, P.
Source :: World Journal of Urology; 1621; 1627; 0724-4983; 10; 36; ~World Journal of Urology~1621~1627~~~0724-4983~10~36~~
Publication Year :: 2018
Abstract: Contains fulltext : 195867.pdf (Publisher’s version ) (Closed access)

Database :: OAIster
Journal :: World Journal of Urology; 1621; 1627; 0724-4983; 10; 36; ~World Journal of Urology~1621~1627~~~0724-4983~10~36~~
Publication Type :: Electronic Resource
Accession number :: edsoai.on1377034644
Document Type :: Electronic Resource

Tools